The following is a summary of “Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1,” published in the March 2025 issue of ...

CHO cells were the protein production platform used in 89% of the biologics drugs approved between 2018 and 2022, and their ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

As U.S. stock markets continue to recover, with major indices closing higher for the third consecutive day, investors are cautiously optimistic about the potential easing of tariffs and its impact on ...

A new treatment possibility has been confirmed for ischemic cardiovascular disease, which does not have a suitable treatment ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

Researchers successfully use a nonviral, piggyBac transposon system to introduce a transgene into cynomolgus monkeys.

Alzheimer's Disease (AD) is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like ...

These findings could help scientists design better treatments for bowel diseases, which take an entirely new approach than ...

FundVantage Trust (PCHI) experienced a near-total loss, with its price plummeting to $0.00001, marking a -99.99% change.

The company plans to file next year for an accelerated clearance of its "exon-skipping" treatment, which would compete with one of Sarepta's medicines.